Chemical genetics and drug screening in Drosophila cancer models

Journal of Genetics and Genomics

Volumn 38, Issue 10, 2011, Pages 497-504

  Gladstone, Mara ^a,b   Su, Tin Tin ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b SuviCa Inc   (United States)

Author keywords

Cancer; Drosophila; Drug screening

Indexed keywords

APC PROTEIN; JANUS KINASE; PROTEIN RET; STAT PROTEIN; WNT PROTEIN;

CANCER GENETICS; CANCER MODEL; CANCER THERAPY; DROSOPHILA MELANOGASTER; DRUG BIOAVAILABILITY; DRUG SCREENING; DRUG UPTAKE; METASTASIS; NONHUMAN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS; TUBEROUS SCLEROSIS;

ANIMALIA; DROSOPHILA MELANOGASTER; RODENTIA;

EID: 80054960898     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2011.09.003     Document Type: Review

References (62)

1. Arbouzova N.I., Zeidler M.P. JAK/STAT signalling in Drosophila: insights into conserved regulatory and cellular functions. Development 2006, 133:2605-2616.
2. Barker N., Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug Discov. 2006, 5:997-1014.
3. Bergantinos C., Vilana X., Corominas M., Serras F. Imaginal discs: renaissance of a model for regenerative biology. Bioessays 2010, 32:207-217.
4. Bhandari P., Shashidhara L.S. Studies on human colon cancer gene APC by targeted expression in Drosophila. Oncogene 2001, 20:6871-6880.
5. Brumby A.M., Richardson H.E. scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J. 2003, 22:5769-5779.
6. Brumby A.M., Richardson H.E. Using Drosophila melanogaster to map human cancer pathways. Nat. Rev. Cancer 2005, 5:626-639.
7. Carlomagno F., Vitagliano D., Guida T., Ciardiello F., Tortora G., Vecchio G., Ryan A.J., Fontanini G., Fusco A., Santoro M. ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases. Cancer Res. 2002, 62:7284-7290.
8. Caussinus E., Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat. Genet. 2005, 37:1125-1129.
9. Chia I.V., Costantini F. Mouse axin and axin2/conductin proteins are functionally equivalent in vivo. Mol. Cell. Biol. 2005, 25:4371-4376.
10. Cohen S. Imaginal disc development. The Development of Drosophila melanogaster 1993, 747-841. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. M. Bate, A.M. Arias (Eds.).
11. Das T., Cagan R. Drosophila as a novel therapeutic discovery tool for thyroid cancer. Thyroid 2010, 20:689-695.
12. DeGregori J., Johnson D.G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 2006, 6:739-748.
13. Dow L.E., Elsum I.A., King C.L., Kinross K.M., Richardson H.E., Humbert P.O. Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Oncogene 2008, 27:5988-6001.
14. Edgar B.A., Weir M.P., Schubiger G., Kornberg T. Repression and turnover pattern fushi tarazu RNA in the early Drosophila embryo. Cell 1986, 47:747-754.
15. Edwards A., Gladstone M., Yoon P., Raben D., Frederick B., Su T.T. Combinatorial effect of maytansinol and radiation in Drosophila and human cancer cells. Dis. Model Mech. 2011, 4:496-503.
16. Fan Y., Bergmann A. Apoptosis-induced compensatory proliferation. The cell is dead. Long live the cell!. Trends Cell Biol. 2008, 18:467-473.
17. Fan Y., Bergmann A. Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye. Dev Cell. 2008, 14:399-410.
18. Feany M.B., Bender W.W. A Drosophila model of Parkinson's disease. Nature 2000, 404:394-398.
19. Frolov M.V., Huen D.S., Stevaux O., Dimova D., Balczarek-Strang K., Elsdon M., Dyson N.J. Functional antagonism between E2F family members. Genes Dev. 2001, 15:2146-2160.
20. Gladstone M., Su T.T. A screen for radiation sensitizers of Drosophila checkpoint mutants. Cell Cycle Checkpoints: Methods and Protocols 2011, Humana Press, 782, 105-117. W. Li (Ed.).
21. Gonsalves F.C., Klein K., Carson B.B., Katz S., Ekas L.A., Evans S., Nagourney R., Cardozo T., Brown A.M., DasGupta R. An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc. Natl. Acad. Sci. USA 2011, 108:5954-5963.
22. Gregorieff A., Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 2005, 19:877-890.
23. Hariharan I.K., Bilder D. Regulation of imaginal disc growth by tumor-suppressor genes in Drosophila. Annu. Rev. Genet. 2006, 40:335-361.
24. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
25. Hijazi A., Haenlin M., Waltzer L., Roch F. The Ly6 protein coiled is required for septate junction and blood brain barrier organisation in Drosophila. PLoS ONE 2011, 6:e17763.
26. Hirsh J. Exposing Drosophila to neuroactive drugs. Drosophila Protocols 2000, 617-623. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. W. Sullivan, M. Ashburner, R.S. Hawley (Eds.).
27. Humbert P.O., Grzeschik N.A., Brumby A.M., Galea R., Elsum I., Richardson H.E. Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene 2008, 27:6888-6907.
28. Jackson G.R., Salecker I., Dong X., Yao X., Arnheim N., Faber P.W., MacDonald M.E., Zipursky S.L. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 1998, 21:633-642.
29. Jackson G.R., Wiedau-Pazos M., Sang T.K., Wagle N., Brown C.A., Massachi S., Geschwind D.H. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 2002, 34:509-519.
30. Jaklevic B., Uyetake L., Lemstra W., Chang J., Leary W., Edwards A., Vidwans S., Sibon O., Su T.T. Contribution of growth and cell cycle checkpoints to radiation survival in Drosophila. Genetics 2006, 174:1963-1972.
31. Januschke J., Gonzalez C. Drosophila asymmetric division, polarity and cancer. Oncogene 2008, 27:6994-7002.
32. Jiang H., Edgar B.A. EGFR signaling regulates the proliferation of Drosophila adult midgut progenitors. Development 2009, 136:483-493.
33. Juang J.L., Carlson S.D. Analog of vertebrate anionic sites in blood-brain interface of larval Drosophila. Cell Tissue Res. 1994, 277:87-95.
34. Karess R. Rod-Zw10-Zwilch: a key player in the spindle checkpoint. Trends Cell Biol. 2005, 15:386-392.
35. Kim B.H., Yin C.H., Guo Q., Bach E.A., Lee H., Sandoval C., Jayabose S., Ulaczyk-Lesanko A., Hall D.G., Baeg G.H. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells. Mol. Cancer Ther. 2008, 7:2672-2680.
36. Martin F.A., Herrera S.C., Morata G. Cell competition, growth and size control in the Drosophila wing imaginal disc. Development 2009, 136:3747-3756.
37. Martin F.A., Perez-Garijo A., Morata G. Apoptosis in Drosophila: compensatory proliferation and undead cells. Int. J. Dev. Biol. 2009, 53:1341-1347.
38. Micchelli C.A., Perrimon N. Evidence that stem cells reside in the adult Drosophila midgut epithelium. Nature 2006, 439:475-479.
39. Orr B., Afonso O., Feijao T., Sunkel C.E. Driving chromosome segregation: lessons from the human and Drosophila centromere-kinetochore machinery. Biochem. Soc. Trans. 2010, 38:1667-1675.
40. Pagliarini R.A., Xu T. A genetic screen in Drosophila for metastatic behavior. Science 2003, 302:1227-1231.
41. Pan D., Dong J., Zhang Y., Gao X. Tuberous sclerosis complex: from Drosophila to human disease. Trends Cell Biol. 2004, 14:78-85.
42. Pandey U.B., Nichols C.D. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol. Rev. 2011, 63:411-436.
43. Peel D.J., Johnson S.A., Milner M.J. The ultrastructure of imaginal disc cells in primary cultures and during cell aggregation in continuous cell lines. Tissue Cell 1990, 22:749-758.
44. Polakis P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 2007, 17:45-51.
45. Radimerski T., Montagne J., Hemmings-Mieszczak M., Thomas G. Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev. 2002, 16:2627-2632.
46. Read R.D., Goodfellow P.J., Mardis E.R., Novak N., Armstrong J.R., Cagan R.L. A Drosophila model of multiple endocrine neoplasia type 2. Genetics 2005, 171:1057-1081.
47. Repiso A., Bergantinos C., Corominas M., Serras F. Tissue repair and regeneration in Drosophila imaginal discs. Dev. Growth Differ. 2011, 53:177-185.
48. Romero-Calderon R., Krantz D.E. Transport of polyamines in Drosophila S2 cells: kinetics, pharmacology and dependence on the plasma membrane proton gradient. Biochem. J. 2006, 393:583-589.
49. Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E., Louis D.N., Settleman J., Haber D.A. A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Res. 2010, 70:2158-2164.
50. Rutkowski R., Hofmann K., Gartner A. Phylogeny and function of the invertebrate p53 superfamily. Cold Spring Harb. Perspect. Biol. 2010, 2:a001131.
51. Ryoo H.D., Baehrecke E.H. Distinct death mechanisms in Drosophila development. Curr. Opin. Cell Biol. 2010, 22:889-895.
52. Ryoo H.D., Gorenc T., Steller H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev. Cell 2004, 7:491-501.
53. Shermoen A. BrdU labeling of chromosomes. Drosophila Protocols 2000, 57-65. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. W. Sullivan, M. Ashburner, R.S. Hawley (Eds.).
54. Su T.T. Cellular responses to DNA damage: one signal, multiple choices. Annu. Rev. Genet. 2006, 40:187-208.
55. Tsen C., Iltis M., Kaur N., Bayer C., Delcros J.G., von Kalm L., Phanstiel O.T. A Drosophila model to identify polyamine-drug conjugates that target the polyamine transporter in an intact epithelium. J. Med. Chem. 2008, 51:324-330.
56. Vidal M., Cagan R.L. Drosophila models for cancer research. Curr. Opin. Genet. Dev. 2006, 16:10-16.
57. Vidal M., Wells S., Ryan A., Cagan R. ZD6474 suppresses oncogenic RET isoforms in a Drosophila model for type 2 multiple endocrine neoplasia syndromes and papillary thyroid carcinoma. Cancer Res. 2005, 65:3538-3541.
58. Wu M., Pastor-Pareja J.C., Xu T. Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature 2010, 463:545-548.
59. Yamaguchi M., Hirose F., Inoue Y.H., Shiraki M., Hayashi Y., Nishi Y., Matsukage A. Ectopic expression of human p53 inhibits entry into S phase and induces apoptosis in the Drosophila eye imaginal disc. Oncogene 1999, 18:6767-6775.
60. Yu C.L., Meyer D.J., Campbell G.S., Larner A.C., Carter-Su C., Schwartz J., Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995, 269:81-83.
61. Yu H., Jove R. The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 2004, 4:97-105.
62. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.